IL-15-Armored CAR-T Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-15-Armored CAR-T Therapy, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia [Phase 2]